BEAM · Beam Therapeutics Inc.

$30.48 +0.29 (+0.96%) At close · Aug 27

Market Cap

$3.12B

103.29M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
10-Q	2026-08-04	2026-06-30
8-K	2026-08-04	—
8-K	2026-06-08	2026-06-03
10-Q	2026-05-07	2026-03-31
8-K	2026-05-07	—
DEF 14A	2026-04-17	2026-06-03
8-K	2026-03-05	2026-03-02
8-K	2026-02-24	—
10-K	2026-02-24	2025-12-31
8-K	2026-02-12	2026-02-09
8-K	2026-02-05	2026-01-31
8-K	2026-01-12	2026-01-11
8-K	2025-12-11	2025-12-08
8-K	2025-11-04	—
10-Q	2025-11-04	2025-09-30
10-Q	2025-08-05	2025-06-30
8-K	2025-08-05	—
8-K	2025-07-03	2025-07-01
8-K	2025-06-06	2025-06-04
10-Q	2025-05-06	2025-03-31
8-K	2025-05-06	—
DEF 14A	2025-04-18	2025-06-04
8-K	2025-03-10	—
8-K	2025-03-10	—
10-K	2025-02-25	2024-12-31
8-K	2025-02-25	—
8-K	2025-01-13	—
8-K	2024-12-09	2024-12-07
8-K	2024-12-06	2024-12-05
8-K	2024-12-04	2024-12-02
8-K	2024-11-05	—
10-Q	2024-11-05	2024-09-30
8-K	2024-11-05	—
8-K	2024-11-05	—
10-Q	2024-08-06	2024-06-30
8-K	2024-08-06	—
8-K	2024-07-15	2024-07-11
8-K	2024-06-10	2024-06-05
8-K	2024-05-07	—
10-Q	2024-05-07	2024-03-31
DEF 14A	2024-04-19	2024-06-05
8-K	2024-02-27	—
10-K	2024-02-27	2023-12-31
8-K	2024-01-08	—
8-K	2023-12-14	2023-12-13
8-K	2023-11-08	—
10-Q	2023-11-08	2023-09-30
8-K	2023-10-31	2023-10-27
8-K	2023-10-19	2023-10-18
8-K	2023-08-08	—

Showing 1–50 of 102 filings

Key facts CIK 1745999 CUSIP 07373V105 13F (30d) 235 filings 228 filers Visit website Investor relations